LeonaBio, Inc. (LONA)

LeonaBio, Inc. (LONA) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $49M; returns 1 day -2.6%, 1 week -6.9%.

LeonaBio, Inc., formerly known as Athira Pharma, is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for diseases with high unmet medical needs. The company aims to improve patients' lives by developing therapies for treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS).

Groups LONA belongs to

• Healthcare
• Biotechnology
• Clinical Stage Biopharma
• Biopharmaceutical
• Clinical Stage Biotech
• Unmet Medical Needs
• Breast Cancer Treatment
• Pharmaceuticals
• Oncology
• Life Sciences
• Neuroscience
• CNS Disorders
• Cancer Therapeutics
• Neurological Disorders

LONA financial model: income statement, cash flow and balance sheet